Envoy Medical, Inc. (COCH) - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2024 Annual Meeting of Stockholders held by Envoy Medical, Inc. on November 14, 2024. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC under the symbols COCH (Class A Common Stock) and COCHW (Redeemable Warrants).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Stockholders approved four key matters at the Annual Meeting:
- Election of Directors: Two Class I director nominees were elected to serve until the 2027 annual meeting.
- Michael Crowe: 11,146,464 votes For; 20,254 Withheld.
- Mona Patel: 11,047,146 votes For; 119,572 Withheld.
- Ratification of Auditors: Grant Thornton LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2024 (13,173,556 For; 12,662 Against).
- Executive Compensation (Say-on-Pay): Stockholders approved the compensation of named executive officers on a non-binding advisory basis (11,117,644 For; 29,673 Against).
- Compensation Vote Frequency: Stockholders recommended a one-year frequency for future advisory votes on executive compensation (11,135,620 votes for 1 year).
Guidance, Outlook, and Management Commentary
Following the stockholder recommendation for annual advisory votes on executive compensation, the Board of Directors has determined to hold such votes every year until the next advisory vote on frequency or until the Board determines a different frequency is in the best interest of the company. No financial guidance or outlook was provided in this filing.
Investor Verification Checklist
- Verify the official appointment of Michael Crowe and Mona Patel to the Board of Directors.
- Confirm the engagement of Grant Thornton LLP for the 2024 fiscal year audit.
- Review the company's proxy statement for details on the specific compensation packages approved.
- Monitor future filings to ensure the Board adheres to the newly adopted annual frequency for executive compensation votes.